PART I . Overview Immunic, Inc. (Immunic," we, us, our or the "Company") is a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic and gastrointestinal diseases. We are headquartered in New York City with our main operations in Grfelfing near Munich, Germany. We had 92 employees as of February 1, 2026. We are pursuing clinical development of orally administered, small molecule programs, each of which has unique features intended to directly address t...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001280776-26-000005 | EDGAR | 81K words |
| 2025-03-31 | 2024-12-31 | 0001280776-25-000005 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0001280776-24-000004 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0001280776-23-000004 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001280776-22-000006 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001280776-21-000009 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001280776-20-000009 | EDGAR | — |
| 2019-03-04 | 2018-12-31 | 0001280776-19-000025 | EDGAR | — |
| 2018-03-13 | 2017-12-31 | 0001280776-18-000013 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001280776-17-000010 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001280776-25-000017 | EDGAR | 29K words |
| 2025-08-07 | 2025-06-30 | 0001280776-25-000012 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001280776-25-000008 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001280776-24-000018 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001280776-24-000014 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001280776-24-000009 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001280776-23-000018 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001280776-23-000013 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001280776-23-000010 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001280776-22-000021 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001280776-22-000017 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001280776-22-000012 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001193805-26-000382 | EDGAR | 1K words |
| 2026-03-31 | 0001193805-26-000370 | EDGAR | — |
| 2026-02-26 | 0001193805-26-000181 | EDGAR | — |
| 2026-02-13 | 0001193805-26-000129 | EDGAR | — |
| 2026-01-06 | 0001193805-26-000011 | EDGAR | — |
| 2026-01-05 | 0001193805-26-000007 | EDGAR | — |
| 2025-11-13 | 0001193805-25-001570 | EDGAR | — |
| 2025-09-25 | 0001193805-25-001357 | EDGAR | — |
| 2025-08-07 | 0001193805-25-001164 | EDGAR | — |
| 2025-07-11 | 0001193805-25-001008 | EDGAR | — |
271 total filings indexed. 239 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001280776 |
| Ticker | IMUX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.imux.com |
| Listed | 2014-04-17 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report